Dr. Gervino is the Director of Clinical Physiology Laboratory at Beth Israel Deaconess Medical Center and serves as the Director of Exercise Testing Core Lab at the Baim Institute for both national and international research trials. He held this role in the Harvard Clinical Research Institute.
His research interests include the stress testing as a primary endpoint, effects of exercise training on management of patients, diet and behavior modification on the reduction of risk for a second cardiac event. He developed the “BI Modified Bruce & Gervino Protocols” for patients with limited functional capacity, allowing for appropriate titration of physiologic responses prior to the patient reaching functional limitations. These stress protocols have been used in national and international clinical research trials in cardiology, neurology, and diabetes.
For over 40 years he has performed cardiopulmonary stress tests on thousands of healthy and diseased patients to determine their metabolic response to exercise. Having trained generations of physicians, medical students and allied health professionals in the field of stress testing, many have become leaders at regional, national, and international levels.
He is a Professor of Medicine at Harvard Medical School, a Professor of Health Sciences and Technology at MIT and has been a member of the Cardiovascular Division since 1981. He has served on AHA, ACC, and FDA review committees.